sequencing

Researchers generated complete genomes of two important bat species and explored their immune- and cancer-related genes.

Researchers get creative using bacterial bits and pieces to produce synthetic cells for studying cancer.

Found circulating in peripheral blood, scientists use cell-free DNA (cfDNA) to assess genetic abnormalities, infections, cancer, transplant rejection, and cardiovascular disease.

A more focused investigation for more in-depth answers.

Multiomics combines multiple layers of biology to power new discoveries in disease research. 

Correlated regions of systemic inter-individual epigenetic variation (CoRSIV) target-capture bisulfite sequencing allows researchers to identify disease-associated epigenetic variation.

How spatial biology techniques evolved over time 

Researchers turn to unique eukaryotes to better understand how DNA is organized in 3D space.

Extracting nucleic acids and proteins gently from samples increases experimental success.

Scientists use an automated liquid handling station to ensure consistency across a range of experiments.

By combining two innovative approaches, researchers can now sequence the full spectrum of mutational differences between individual cells’ genomes.

Metagenomic sequencing can help detect unknown pathogens, but its widespread use faces challenges.

Translational scientists discuss their experiences taking preclinical concepts to the market.

A high-quality reference genome for this vulnerable feline may help scientists understand why they’re so prone to transitional cell carcinoma in captivity.

Discover the benefits of targeted sequencing!

Researchers show how a toxic therapy helped identify a mummy using preserved DNA.

This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.

Identify small impurities introduced by oligonucleotide synthesis prior to experimentation.

Most differences in gene expression among cells within a tumor are likely due to environment or noise, a study suggests. 

Researchers reduce therapeutic CAR T cell heterogeneity with targeted single-cell transcriptomics.